News

March 25, 2025

TwoStep Therapeutics Selected to Join Johnson & Johnson’s Global Incubator Network “JLABS”

March 19, 2025

TwoStep Therapeutics Unveils Its Lead Tumor-Targeted Drug Conjugate and New Radiopharmaceutical Program at Debut Scientific Presentation

February 13, 2025

J&J’s JLABS Company Spotlight on TwoStep Therapeutics

June 27, 2024

Bertozzi’s TwoStep Therapeutics to Target Solid Tumors With Engineered Peptide Drug Delivery Vehicle

June 25, 2024

TwoStep Therapeutics Launches with Funding to Advance Broadly Applicable Targeting Platform for Solid Tumors

June 25, 2024

New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi

Recent Publications

Systemic delivery of a targeted synthetic immunostimulant transforms the immune landscape for effective tumor regression

Caitlyn L Miller, Idit Sagiv-Barfi, Patrick Neuhöfer, Debra K Czerwinski, Steven E Artandi, Carolyn R Bertozzi, Ronald Levy, Jennifer R Cochran

Cell Chemical Biology, 2022

Targeted TLR9 Agonist Elicits Effective Antitumor Immunity against Spontaneously Arising Breast Tumors

Caitlyn L Miller, Idit Sagiv-Barfi, Patrick Neuhöfer, Debra K Czerwinski, Carolyn R Bertozzi, Jennifer R Cochran, Ronald Levy

The Journal of Immunology, 2023